NASDAQ : CUE
Cue Biopharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 20.87 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 151.61M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cue Biopharma, Inc. (CUE) reported revenue of 37.66M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 37.66M | 27.47M | 9.29M | 5.49M | 1.25M | 14.94M |
| Cost of Revenue | 74.99M | 34.84M | 32.90M | 40.80M | 35.30M | 41.35M |
| Gross Profit | -37.34M | -7.38M | -23.61M | -35.31M | -34.05M | -26.41M |
| Selling, General & Admin | 61.31M | 19.14M | 17.98M | 16.68M | 19.45M | 17.31M |
| Operating Expenses | 61.31M | 19.14M | 17.98M | 16.68M | 19.45M | 17.31M |
| Operating Income | -98.64M | -26.52M | -41.59M | -51.99M | -53.50M | -43.71M |
| Interest Expense | -194.00K | -357.00K | -796.00K | -1.25M | -713.00K | |
| Interest & Investment Income | 775.00K | 807.00K | 1.62M | 2.66M | 928.00K | 45.90K |
| Other Non Operating Income (Expenses) | -65.52M | |||||
| EBT Excluding Unusual Items | -163.59M | -26.07M | -40.77M | -50.58M | -53.29M | -43.67M |
| Gain (Loss) on Sale of Assets | -31.00K | -31.00K | 93.00K | -157.00K | 277.00K | |
| Pretax Income | -163.61M | -26.10M | -40.67M | -50.73M | -53.01M | -43.67M |
| Income Tax Expense | 500.00K | 500.00K | 495.00K | |||
| Net Income | -164.11M | -26.60M | -40.67M | -50.73M | -53.01M | -44.16M |
| Net Income to Common | -164.11M | -26.60M | -40.67M | -50.73M | -53.01M | -44.16M |
| Shares Outstanding (Basic) | 4.53M | 3.16M | 1.88M | 1.53M | 1.19M | 1.04M |
| Shares Outstanding (Diluted) | 4.53M | 3.16M | 1.88M | 1.53M | 1.19M | 1.04M |
| EPS (Basic) | -36.22 | -8.42 | -21.66 | -33.26 | -44.61 | -42.35 |
| EPS (Diluted) | -36.22 | -8.42 | -21.66 | -33.26 | -44.61 | -42.35 |
| Free Cash Flow | -50.17M | -21.86M | -36.40M | -39.96M | -41.98M | -39.75M |
| Free Cash Flow Per Share | -11.07 | -6.92 | -19.38 | -26.20 | -35.33 | -38.12 |
| Gross Margin | -99.15% | -26.86% | -254.21% | -176.73% | ||
| Operating Margin | -261.97% | -96.56% | -447.86% | -947.03% | -4,297.35% | -292.56% |
| Profit Margin | -435.82% | -96.85% | -437.97% | -924.10% | -4,257.83% | -295.56% |
| Free Cash Flow Margin | -133.23% | -79.60% | -391.89% | -727.89% | -3,371.65% | -266.04% |
| EBITDA | -97.28M | -25.56M | -41.20M | -51.44M | -52.58M | -42.45M |
| EBITDA Margin | -258.36% | -93.07% | -284.14% | |||
| D&A For EBITDA | 1.36M | 958.00K | 397.00K | 556.00K | 922.00K | 1.26M |
| EBIT | -98.64M | -26.52M | -41.59M | -51.99M | -53.50M | -43.71M |
| EBIT Margin | -261.97% | -96.56% | -292.56% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 17.39M | 27.14M | 22.46M | 48.51M | 51.61M | 64.37M |
| Short-Term Investments | 22.00K | 1.09M | 929.00K | 287.00K | 24.68M | |
| Cash & Short-Term Investments | 17.41M | 28.23M | 23.39M | 48.80M | 76.29M | 64.37M |
| Accounts Receivable | 5.38M | 5.55M | 945.00K | 1.70M | 57.00K | 3.14M |
| Other Receivables | 1.90M | |||||
| Receivables | 5.38M | 7.45M | 945.00K | 1.70M | 57.00K | 3.14M |
| Prepaid Expenses | 1.93M | 1.31M | 805.00K | 955.00K | 841.00K | 874.79K |
| Other Current Assets | 1.90M | 80.00K | ||||
| Total Current Assets | 26.62M | 36.98M | 25.14M | 51.45M | 77.19M | 68.47M |
| Property, Plant & Equipment | 3.21M | 4.32M | 4.84M | 7.12M | 10.70M | 11.92M |
| Other Long-Term Assets | 870.00K | 914.00K | 2.21M | 2.96M | 3.39M | 3.01M |
| Total Assets | 30.71M | 42.21M | 32.19M | 61.53M | 91.28M | 83.40M |
| Accounts Payable | 3.75M | 3.95M | 2.82M | 3.50M | 2.73M | 2.59M |
| Accrued Expenses | 14.88M | 1.61M | 2.91M | 4.14M | 3.55M | 4.62M |
| Current Portion of Long-Term Debt | 4.33M | 3.96M | 1.96M | |||
| Current Portion of Leases | 1.63M | 1.91M | 3.54M | 3.37M | 3.30M | 4.93M |
| Current Unearned Revenue | 5.33M | 85.00K | 2.11M | 645.34K | ||
| Other Current Liabilities | 960.00K | 689.00K | 1.00 | |||
| Total Current Liabilities | 21.22M | 13.49M | 13.69M | 17.08M | 11.55M | 12.79M |
| Long-Term Debt | 4.20M | 8.04M | ||||
| Long-Term Leases | 1.45M | 2.29M | 1.00M | 3.16M | 6.02M | 5.12M |
| Other Long-Term Liabilities | 5.73M | |||||
| Total Liabilities | 28.40M | 15.78M | 14.69M | 24.45M | 25.60M | 17.91M |
| Common Stock | 5.00K | 97.00K | 62.00K | 47.00K | 43.00K | 32.20K |
| Additional Paid-In Capital | 529.02M | 394.80M | 359.30M | 338.23M | 316.19M | 262.91M |
| Retained Earnings | -526.71M | -368.47M | -341.86M | -301.19M | -250.46M | -197.45M |
| Comprehensive Income & Other | -96.00K | |||||
| Shareholders' Equity | 2.31M | 26.43M | 17.50M | 37.09M | 65.68M | 65.49M |
| Total Liabilities & Equity | 30.71M | 42.21M | 32.19M | 61.53M | 91.28M | 83.40M |
| Total Debt | 3.08M | 4.20M | 8.88M | 14.70M | 19.32M | 10.05M |
| Net Cash (Debt) | 14.34M | 24.03M | 14.51M | 34.11M | 56.97M | 54.32M |
| Net Cash Per Share | 3.16 | 7.61 | 7.73 | 22.36 | 47.94 | 52.09 |
| Filing Date Shares Outstanding | 7.26M | 3.26M | 2.06M | 1.62M | 1.44M | 1.10M |
| Total Common Shares Outstanding | 5.23M | 3.22M | 2.06M | 1.57M | 1.43M | 1.07M |
| Working Capital | 5.41M | 23.49M | 11.45M | 34.37M | 65.64M | 55.68M |
| Book Value Per Share | 0.44 | 8.21 | 8.49 | 23.56 | 45.78 | 61.01 |
| Tangible Book Value | 2.31M | 26.43M | 17.50M | 37.09M | 65.68M | 65.49M |
| Tangible Book Value Per Share | 0.44 | 8.21 | 8.49 | 23.56 | 45.78 | 61.01 |
| Machinery | 3.91M | 3.79M | 4.03M | 4.29M | 5.62M | 5.55M |
| Leasehold Improvements | 118.00K | 118.00K | 118.00K | 118.00K | 118.00K | 6.53K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -164.11M | -26.60M | -40.67M | -50.73M | -53.01M | -44.16M |
| Depreciation & Amortization | 3.88M | 3.48M | 2.35M | 3.44M | 1.81M | 1.26M |
| Other Amortization | 19.00K | 37.00K | 37.00K | 37.00K | 31.00K | |
| Loss (Gain) From Sale of Assets | 31.00K | 31.00K | -93.00K | 157.00K | 4.00K | -21.55K |
| Loss (Gain) From Sale of Investments | -212.00K | -212.00K | -234.00K | -321.00K | -4.58K | |
| Stock-Based Compensation | 26.03M | 4.74M | 6.85M | 8.18M | 9.50M | 11.52M |
| Other Operating Activities | 82.50M | 130.00K | 130.00K | 130.00K | -168.00K | -3.04M |
| Change in Accounts Receivable | -4.84M | -4.60M | 753.00K | -1.64M | 3.08M | -1.73M |
| Change in Accounts Payable | 120.00K | 1.12M | -678.00K | 770.00K | 83.00K | 520.40K |
| Change in Unearned Revenue | -9.58M | 5.25M | -2.03M | 2.11M | -645.00K | -7.97M |
| Change in Other Net Operating Assets | 16.11M | -5.07M | -2.97M | -2.17M | -2.17M | 4.79M |
| Operating Cash Flow | -50.05M | -21.69M | -36.33M | -39.96M | -41.81M | -38.84M |
| Capital Expenditures | -121.00K | -177.00K | -66.00K | -171.00K | -913.04K | |
| Sale of Property, Plant & Equipment | 40.00K | 40.00K | 98.00K | 2.00K | 6.00K | 21.55K |
| Investment in Securities | 212.00K | 212.00K | 25.00M | -24.45M | 10.00M | |
| Investing Cash Flow | 131.00K | 75.00K | 32.00K | 25.00M | -24.61M | 9.11M |
| Long-Term Debt Issued | 10.00M | |||||
| Long-Term Debt Repaid | -4.50M | -4.00M | -2.00M | |||
| Net Debt Issued (Repaid) | -2.50M | -4.50M | -4.00M | -2.00M | 10.00M | |
| Issuance of Common Stock | 32.81M | 30.79M | 14.24M | 13.86M | 39.30M | 19.98M |
| Repurchase of Common Stock | -200.00K | -750.13K | ||||
| Other Financing Activities | 9.50M | 4.56M | ||||
| Financing Cash Flow | 39.82M | 26.29M | 10.24M | 11.86M | 53.66M | 19.23M |
| Net Cash Flow | -10.10M | 4.68M | -26.05M | -3.10M | -12.76M | -10.50M |
| Free Cash Flow | -50.17M | -21.86M | -36.40M | -39.96M | -41.98M | -39.75M |
| Free Cash Flow Margin | -133.23% | -79.60% | -391.89% | -727.89% | -3,371.65% | -266.04% |
| Free Cash Flow Per Share | -11.07 | -6.92 | -19.38 | -26.20 | -35.33 | -38.12 |
| Levered Free Cash Flow | -33.43M | -9.95M | -20.36M | -19.91M | -21.09M | -20.32M |
| Unlevered Free Cash Flow | -33.32M | -9.77M | -19.90M | -19.17M | -20.68M | -20.32M |
| Cash Interest Paid | 57.00K | 214.00K | 669.00K | 1.00M | 570.00K | |
| Cash Income Tax Paid | 495.00K | |||||
| Change in Working Capital | 1.81M | -3.29M | -4.92M | -934.00K | 356.00K | -4.39M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 144.96M | 27.86M | 69.05M | 119.13M | 122.67M | 359.22M |
| Enterprise Value | 130.62M | 13.62M | 46.14M | 80.81M | 83.10M | 295.22M |
| Last Close Price | 20.87 | 9.16 | 32.70 | 79.20 | 85.50 | 339.30 |
| PS Ratio | 3.85 | 1.01 | 7.43 | 21.70 | 98.53 | 24.04 |
| PB Ratio | 47.25 | 1.05 | 3.95 | 3.21 | 1.87 | 5.49 |
| P/TBV Ratio | 62.71 | 1.05 | 3.95 | 3.21 | 1.87 | 5.49 |
| EV/Sales Ratio | 3.47 | 0.50 | 4.97 | 14.72 | 66.75 | 19.76 |
| Debt / Equity Ratio | 1.33 | 0.16 | 0.51 | 0.40 | 0.29 | 0.15 |
| Net Debt / Equity Ratio | -6.21 | -0.91 | -0.83 | -0.92 | -0.87 | -0.83 |
| Net Debt / EBITDA Ratio | 0.15 | 0.94 | 0.35 | 0.66 | 1.08 | 1.28 |
| Net Debt / FCF Ratio | 0.29 | 1.10 | 0.40 | 0.85 | 1.36 | 1.37 |
| Asset Turnover | 1.05 | 0.74 | 0.20 | 0.07 | 0.01 | 0.16 |
| Quick Ratio | 1.07 | 2.64 | 1.78 | 2.96 | 6.61 | 5.28 |
| Current Ratio | 1.25 | 2.74 | 1.84 | 3.01 | 6.68 | 5.35 |
| Return on Equity (ROE) | -1,603.48% | -121.11% | -149.03% | -98.73% | -80.82% | -61.16% |
| Return on Assets (ROA) | -172.66% | -44.56% | -55.47% | -42.53% | -38.29% | -29.87% |
| Return on Capital Employed (ROCE) | -1,039.60% | -92.30% | -224.80% | -117.00% | -67.10% | -61.90% |
| Earnings Yield | -181.52% | -95.47% | -58.90% | -42.59% | -43.21% | -12.29% |
| FCF Yield | -34.63% | -78.47% | -52.71% | -33.55% | -34.22% | -11.07% |
| Buyback Yield / Dilution | -84.06% | -68.18% | -23.11% | -28.35% | -13.95% | -9.05% |